STOCK TITAN

The BC Bud Co Announces Upsized Financing and Closing of 2nd Tranche

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Negative)
Tags

The BC Bud (BCBC) has announced an increase in its non-brokered private placement from $1 million to $1.5 million due to high demand. The company has completed the second tranche of the placement, raising $511,275 through the sale of 6,816,998 units at $0.075 per unit. Each unit includes one common share and one purchase warrant, allowing holders to acquire an additional share at $0.15 within 24 months.

The company previously closed the first tranche on January 17, 2025, raising $631,300. Total proceeds to date amount to $1.142 million through 15,234,330 units. The proceeds will support business development and working capital. Additionally, BCBC has granted 8 million stock options to directors, officers, and consultants, exercisable at $0.12 per share for two years.

BC Bud (BCBC) ha annunciato un aumento della sua offerta privata non mediata da 1 milione a 1,5 milioni di dollari a causa dell'alta domanda. L'azienda ha completato la seconda tranche dell'offerta, raccogliendo 511.275 dollari attraverso la vendita di 6.816.998 unità a 0,075 dollari per unità. Ogni unità comprende un'azione comune e un warrant d'acquisto, che consente ai detentori di acquisire un'ulteriore azione a 0,15 dollari entro 24 mesi.

L'azienda ha precedentemente chiuso la prima tranche il 17 gennaio 2025, raccogliendo 631.300 dollari. I proventi totali fino ad oggi ammontano a 1,142 milioni di dollari tramite 15.234.330 unità. I proventi supporteranno lo sviluppo aziendale e il capitale circolante. Inoltre, BCBC ha concesso 8 milioni di opzioni su azioni a direttori, funzionari e consulenti, esercitabili a 0,12 dollari per azione per due anni.

BC Bud (BCBC) ha anunciado un aumento en su colocación privada no mediada de 1 millón a 1,5 millones de dólares debido a la alta demanda. La compañía ha completado la segunda tranche de la colocación, recaudando 511,275 dólares a través de la venta de 6,816,998 unidades a 0,075 dólares por unidad. Cada unidad incluye una acción común y una opción de compra, que permite a los tenedores adquirir una acción adicional a 0,15 dólares dentro de los 24 meses.

La empresa cerró previamente la primera tranche el 17 de enero de 2025, recaudando 631,300 dólares. Los ingresos totales hasta la fecha ascienden a 1,142 millones de dólares a través de 15,234,330 unidades. Los ingresos apoyarán el desarrollo empresarial y el capital de trabajo. Además, BCBC ha otorgado 8 millones de opciones sobre acciones a directores, funcionarios y consultores, que se pueden ejercer a 0,12 dólares por acción durante dos años.

BC Bud (BCBC)는 높은 수요로 인해 비중개 사모펀드의 규모를 100만 달러에서 150만 달러로 늘렸다고 발표했습니다. 이 회사는 두 번째 분할을 완료하고 0.075달러에 6,816,998 단위를 판매하여 511,275달러를 모금했습니다. 각 단위는 하나의 보통주와 하나의 구매권을 포함하고 있으며, 이를 통해 보유자는 24개월 이내에 0.15달러에 추가 주식을 취득할 수 있습니다.

회사는 2025년 1월 17일 첫 번째 분할을 완료하고 631,300달러를 모금했습니다. 현재까지 총 수익은 15,234,330단위를 통해 1.142백만 달러에 달합니다. 이 수익은 사업 개발 및 운영 자본을 지원하는 데 사용됩니다. 또한, BCBC는 800만 개의 주식 옵션을 이사, 임원 및 고문에게 부여하였으며, 이는 2년 동안 주당 0.12달러에 행사할 수 있습니다.

BC Bud (BCBC) a annoncé une augmentation de son placement privé non intermédiare, passant de 1 million à 1,5 million de dollars en raison d'une forte demande. L'entreprise a complété la deuxième tranche du placement, levant 511 275 dollars grâce à la vente de 6 816 998 unités à 0,075 dollars l'unité. Chaque unité comprend une action ordinaire et un bon de souscription, permettant aux détenteurs d'acquérir une action supplémentaire à 0,15 dollars dans un délai de 24 mois.

L'entreprise a précédemment clôturé la première tranche le 17 janvier 2025, levant 631 300 dollars. Les recettes totales jusqu'à présent s'élèvent à 1,142 million de dollars grâce à 15 234 330 unités. Les recettes soutiendront le développement commercial et le fonds de roulement. De plus, BCBC a accordé 8 millions d'options sur actions aux administrateurs, dirigeants et consultants, exerçables à 0,12 dollars par action pendant deux ans.

BC Bud (BCBC) hat eine Erhöhung seiner nicht vermittelten Privatplatzierung von 1 Million auf 1,5 Millionen Dollar aufgrund der hohen Nachfrage angekündigt. Das Unternehmen hat die zweite Tranche der Platzierung abgeschlossen und 511.275 Dollar durch den Verkauf von 6.816.998 Einheiten zu je 0,075 Dollar pro Einheit eingebracht. Jede Einheit umfasst eine Stammaktie und ein Zeichnungsrecht, das den Inhabern ermöglicht, innerhalb von 24 Monaten eine zusätzliche Aktie zu einem Preis von 0,15 Dollar zu erwerben.

Das Unternehmen hat die erste Tranche zuvor am 17. Januar 2025 abgeschlossen und dabei 631.300 Dollar gesammelt. Insgesamt belaufen sich die bisherigen Einnahmen auf 1,142 Millionen Dollar durch 15.234.330 Einheiten. Die Einnahmen werden die Geschäftsentwicklung und das Working Capital unterstützen. Darüber hinaus hat BCBC 8 Millionen Aktienoptionen an Direktoren, Führungskräfte und Berater gewährt, die für zwei Jahre zu einem Preis von 0,12 Dollar pro Aktie ausgeübt werden können.

Positive
  • Increased private placement size by 50% to $1.5M due to high demand
  • Successfully raised $1.142M to date through unit sales
  • No finder's fees paid, maximizing capital efficiency
Negative
  • Potential dilution from issuance of up to 20M new units
  • Additional dilution risk from 8M stock options granted
  • Warrants could lead to further dilution if exercised

Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - The BC Bud Corporation (CSE: BCBC) (OTC Pink: BCBCF) (FSE: W04) ("The BC Bud Co" or the "Company"), is pleased to announce that, further to its news release dated January 9, 2025, due to significant demand, it has increased the size of its previously announced non-brokered private placement (the "Placement") to up to $1.5 million (previously $1 million). Under the upsized Placement, the Company will issue up to 20 million units (each a "Unit") at a price of $0.075 per Unit for aggregate gross proceeds of up to $1.5 million.

Additionally, the Company announces that it has closed the second tranche of the Placement raising gross proceeds of $511,275 through the sale of 6,816,998 Units. Each Unit is comprised of one common share and one share purchase warrant. Each warrant will entitle the holder to acquire an additional common share at a price of $0.15 per share for a period of 24 months. The Company previously closed the first tranche of the Placement on January 17, 2025 for aggregate gross proceeds of $631,300. To date, the Company has raised aggregate gross proceeds of $1.142 million through the sale of an aggregate of 15,234,330 Units. Please refer to the Company's news releases dated January 17, 2025 and January 9, 2025 for additional details regarding the Placement.

No finder's fees were paid in connection with the first or second tranche of the Placement. All securities issued in the second tranche are subject to a statutory hold period expiring on May 25, 2025, in accordance with applicable securities legislation.

Net proceeds of the Placement will be utilized for business development and general working capital purposes.

Grant of Options

The Company also announces that it has issued an aggregate of 8 million incentive stock options ("Options") to certain directors, officers and consultants of the Company, pursuant to the Company's omnibus share incentive plan. Each Option is exercisable by the holder to purchase one common share of the Company at an exercise price of $0.12 for a period of two years.

About The BC Bud Co.

The B.C. Bud Co. is a house of brands created by industry professionals who are passionate about the user experience.

On behalf of the board of directors of The BC Bud Co.

Brayden Sutton
Chief Executive Officer and Director

Investor Relations
Phone: 1-(778)-656-0377
Email: info@thebcbc.com
Web: www.thebcbc.com

Disclaimer
Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-Looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding the anticipated use of the net proceeds of the Placement. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

In making the forward-looking statements in this news release, the Company has applied certain material assumptions, including without limitation, that the Company will use the net proceeds of the Placement as currently anticipated and that the Company's business plans will remain unchanged. These forward‐looking statements involve numerous risks and uncertainties, and actual results might differ materially from results suggested in any forward-looking statements. These risks and uncertainties include, among other things, that the Company will not use the net proceeds of the Placement as currently anticipated, unanticipated costs and changes in the Company's business plans, regulatory changes, or other changes impacting the use of the net proceeds of the Placement.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.

Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/238292

FAQ

How much did BCBCF raise in the second tranche of its private placement?

BCBCF raised $511,275 in the second tranche through the sale of 6,816,998 units at $0.075 per unit.

What are the terms of BCBCF's warrant offering in the January 2025 placement?

Each warrant allows holders to purchase one additional common share at $0.15 for a period of 24 months.

How many stock options did BCBCF grant and at what price?

BCBCF granted 8 million stock options exercisable at $0.12 per share for a two-year period.

What is the total amount raised by BCBCF in both tranches of the 2025 private placement?

BCBCF has raised a total of $1.142 million through both tranches of the private placement.

When do the securities from BCBCF's second tranche become freely tradeable?

The securities from the second tranche have a statutory hold period expiring on May 25, 2025.

Bc Bud Corp

OTC:BCBCF

BCBCF Rankings

BCBCF Latest News

BCBCF Stock Data

8.76M
69.35M
35.67%
2.99%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Vancouver